share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Borgeson Blake

Recursion Pharmaceuticals | 4：持股變動聲明-董事 Borgeson Blake
美股SEC公告 ·  09/06 05:29

牛牛AI助理已提取核心訊息

On September 3, 2024, Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock at a price of $6.2652 per share. The transaction, conducted on the open market, resulted in a total value of approximately $71,717.74. Following the sale, Borgeson directly holds a total of 7,121,322 shares in the company. This sale reflects a transaction in Recursion Pharmaceuticals' stock and may be of interest to current or potential investors.
On September 3, 2024, Blake Borgeson, associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 11,447 shares of Class A Common Stock at a price of $6.2652 per share. The transaction, conducted on the open market, resulted in a total value of approximately $71,717.74. Following the sale, Borgeson directly holds a total of 7,121,322 shares in the company. This sale reflects a transaction in Recursion Pharmaceuticals' stock and may be of interest to current or potential investors.
2024年9月3日，與Recursion Pharmaceuticals，Inc. [RXRX]相關的Blake Borgeson以每股6.2652美元的價格出售了11,447股A類普通股。這筆交易在公開市場上進行，總價值約爲71,717.74美元。在此次交易之後，Borgeson直接持有公司總計7,121,322股。這次出售反映了Recursion Pharmaceuticals的股票交易，對現有或潛在的投資者可能會感興趣。
2024年9月3日，與Recursion Pharmaceuticals，Inc. [RXRX]相關的Blake Borgeson以每股6.2652美元的價格出售了11,447股A類普通股。這筆交易在公開市場上進行，總價值約爲71,717.74美元。在此次交易之後，Borgeson直接持有公司總計7,121,322股。這次出售反映了Recursion Pharmaceuticals的股票交易，對現有或潛在的投資者可能會感興趣。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間